These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21261439)

  • 1. Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice.
    Fair PA; Driscoll E; Mollenhauer MA; Bradshaw SG; Yun SH; Kannan K; Bossart GD; Keil DE; Peden-Adams MM
    J Immunotoxicol; 2011; 8(1):17-29. PubMed ID: 21261439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate.
    Peden-Adams MM; Keller JM; Eudaly JG; Berger J; Gilkeson GS; Keil DE
    Toxicol Sci; 2008 Jul; 104(1):144-54. PubMed ID: 18359764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice.
    Mollenhauer MA; Bradshaw SG; Fair PA; McGuinn WD; Peden-Adams MM
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2011; 46(2):97-108. PubMed ID: 21170772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha).
    Qazi MR; Xia Z; Bogdanska J; Chang SC; Ehresman DJ; Butenhoff JL; Nelson BD; DePierre JW; Abedi-Valugerdi M
    Toxicology; 2009 Jun; 260(1-3):68-76. PubMed ID: 19464571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 28-Day dietary exposure of mice to a low total dose (7 mg/kg) of perfluorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: does the route of administration play a pivotal role in PFOS-induced immunotoxicity?
    Qazi MR; Nelson BD; Depierre JW; Abedi-Valugerdi M
    Toxicology; 2010 Jan; 267(1-3):132-9. PubMed ID: 19900501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro PFOS exposure on immune endpoints in bottlenose dolphins (Tursiops truncatus) and mice.
    Wirth JR; Peden-Adams MM; White ND; Bossart GD; Fair PA
    J Appl Toxicol; 2014 Jun; 34(6):658-66. PubMed ID: 23722986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental toxicity in white leghorn chickens following in ovo exposure to perfluorooctane sulfonate (PFOS).
    Peden-Adams MM; Stuckey JE; Gaworecki KM; Berger-Ritchie J; Bryant K; Jodice PG; Scott TR; Ferrario JB; Guan B; Vigo C; Boone JS; McGuinn WD; DeWitt JC; Keil DE
    Reprod Toxicol; 2009 Jun; 27(3-4):307-318. PubMed ID: 19071210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicokinetics of perfluorooctane sulfonate in rabbits under environmentally realistic exposure conditions and comparative assessment between mammals and birds.
    Tarazona JV; Rodríguez C; Alonso E; Sáez M; González F; San Andrés MD; Jiménez B; San Andrés MI
    Toxicol Lett; 2016 Jan; 241():200-6. PubMed ID: 26562771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice.
    Dong GH; Liu MM; Wang D; Zheng L; Liang ZF; Jin YH
    Arch Toxicol; 2011 Oct; 85(10):1235-44. PubMed ID: 21327619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations.
    Thibodeaux JR; Hanson RG; Rogers JM; Grey BE; Barbee BD; Richards JH; Butenhoff JL; Stevenson LA; Lau C
    Toxicol Sci; 2003 Aug; 74(2):369-81. PubMed ID: 12773773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonic-induced tonic convulsion in rats after subchronic exposure to perfluorooctane sulfonate (PFOS).
    Kawamoto K; Sato I; Tsuda S; Yoshida M; Yaegashi K; Saito N; Liu W; Jin Y
    J Toxicol Sci; 2011 Jan; 36(1):55-62. PubMed ID: 21297341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation.
    Lau C; Thibodeaux JR; Hanson RG; Rogers JM; Grey BE; Stanton ME; Butenhoff JL; Stevenson LA
    Toxicol Sci; 2003 Aug; 74(2):382-92. PubMed ID: 12773772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism.
    Yu WG; Liu W; Jin YH
    Environ Toxicol Chem; 2009 May; 28(5):990-6. PubMed ID: 19045937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis.
    Cui L; Zhou QF; Liao CY; Fu JJ; Jiang GB
    Arch Environ Contam Toxicol; 2009 Feb; 56(2):338-49. PubMed ID: 18661093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system.
    Yu WG; Liu W; Jin YH; Liu XH; Wang FQ; Liu L; Nakayama SF
    Environ Sci Technol; 2009 Nov; 43(21):8416-22. PubMed ID: 19924978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study on oxidative damage and distributions of perfluorooctane sulfonate (PFOS) in mice at different postnatal developmental stages.
    Liu L; Liu W; Song J; Yu H; Jin Y; Oami K; Sato I; Saito N; Tsuda S
    J Toxicol Sci; 2009 Jun; 34(3):245-54. PubMed ID: 19483379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 and Type 2 cytokines imbalance in adult male C57BL/6 mice following a 7-day oral exposure to perfluorooctanesulfonate (PFOS).
    Zheng L; Dong GH; Zhang YH; Liang ZF; Jin YH; He QC
    J Immunotoxicol; 2011; 8(1):30-8. PubMed ID: 21299352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse.
    Abbott BD; Wolf CJ; Das KP; Zehr RD; Schmid JE; Lindstrom AB; Strynar MJ; Lau C
    Reprod Toxicol; 2009 Jun; 27(3-4):258-265. PubMed ID: 18595657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity assessment of perfluorooctane sulfonate using acute and subchronic male C57BL/6J mouse models.
    Xing J; Wang G; Zhao J; Wang E; Yin B; Fang D; Zhao J; Zhang H; Chen YQ; Chen W
    Environ Pollut; 2016 Mar; 210():388-96. PubMed ID: 26807985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice.
    Dong GH; Zhang YH; Zheng L; Liu W; Jin YH; He QC
    Arch Toxicol; 2009 Sep; 83(9):805-15. PubMed ID: 19343326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.